June 2026, UN Member States convened at the UN General Assembly High-Level Meeting in New York to consider and agree a new ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) for Yeztugo® (lenacapavir) 300-mg tablet as a ...
Professor Tulio de Oliveira said that a new HIV prevention injection offers six months of protection, while similar long-acting treatments could soon replace daily pills.
In the ongoing effort to find new therapeutics for infants born infected with the human immunodeficiency virus, an ...
For decades, HIV has been treated as a lifelong condition. Medicines can control it well, but they rarely eliminate it. Now, a case is shifting that belief. A 63-year-old man has remained free of ...
Medical advancements over the last several decades have made great strides in the treatment of HIV. Pharmaceutical treatments ...
Tessera Therapeutics Inc. has received a grant from the Gates Foundation to support early-stage research exploring multiple genetic approaches aimed at developing a scalable cure for HIV. This ...
Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective antiretroviral therapy, immune cells infected with HIV can hide and lie inactive ...
A team of Gladstone scientists—including Ashley George (left) and Nadia Roan (right)—uncovered a new path toward life without daily HIV pills, suggesting that a common diabetes pill could help achieve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results